Relmada Therapeutics, Inc.
USD5.30
+0.30 (+6.00%)
CEO
Sergio Traversa
IPO Date
2014-06-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.99
Prev. Close
$5.00
Day Low
$4.86
Day High
$5.43
52W Low
$0.55
52W High
$8.00
Market Cap
$0.56B
Volume
2.67M
| 1,198,000 |
| $4.06 |
| 16 Dec 2025 | Shenouda Maged | Chief Financial Officer | P-Purchase | Acquired | 11,665 | $4.12 |
| 16 Dec 2025 | Shenouda Maged | Chief Financial Officer | A-Award | Acquired | 828,000 | $4.06 |
| 16 Dec 2025 | Ence Chuck | CA and CO | A-Award | Acquired | 828,000 | $4.06 |
| 16 Dec 2025 | Fedeli Fabiana | director | A-Award | Acquired | 164,000 | $4.06 |
| 16 Dec 2025 | GLASSPOOL JOHN | director | A-Award | Acquired | 164,000 | $4.06 |
| 16 Dec 2025 | Kelly Paul Edward | director, officer: COO | A-Award | Acquired | 828,000 | $4.06 |
| 16 Dec 2025 | CASAMENTO CHARLES J | director | A-Award | Acquired | 164,000 | $4.06 |
| 6 Nov 2025 | Shenouda Maged | Chief Financial Officer | P-Purchase | Acquired | 500,000 | $2.20 |